Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: A phase i clinical trial

Jeffrey S. Heier, David Brown, Thomas Ciulla, Prema Abraham, Joy M. Bankert, Sandy Chong, Paul E. Daniel, Ivana K. Kim

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: A phase i clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences